Gauze_Petrolatum

The Defense Health Agency (DHA) Medical Logistics (MEDLOG) Division Medical Materiel Enterprise Standardization Office (MMESO) and the Defense Logistics Agency (DLA) Troop Support Medical Prime Vendor (PV) Program announce a Sources Sought Notification for the creation of a Qualified Suppliers Listing (QSL) for Gauze, Petrolatum. This is not a request for quote or proposal. The MMESO South is the lead MMESO for this project. These Gauze, Petrolatum products are for purchase by the Military Treatment Facilities (MTFs) of the Military Health System (MHS) and for the operational assemblages of the Army, Navy, Air Force, Marine Corps, and Naval Expeditionary Medical Support Command (NEMSCOM) and managed regionally by MMESOs North, South, West, Pacific and Europe, hereafter referred to as MMESOs. For information regarding DLA Troop Support Medical's PV program please access its web site at https://www.medical.dla.mil. This Sources Sought notification is intended to solicit information and products for evaluation in order to create a QSL for Gauze, Petrolatum in accordance with (IAW) FAR 9.2. All items proposed to be included in this QSL must be on a Distribution and Pricing Agreement (DAPA) for the DLA Troop Support Medical/Surgical Prime Vendor (MSPV) Program. All participating vendors must complete the certification in the DAPA Management System (DMS). The MSPV Program requires that all items be manufactured in a Trade Agreements Act (TAA) Compliant Country (see DFARS 252.225-7020 AND 252.225-7021), unless it is determined that no functionally equivalent item is available from a compliant source. To be eligible for inclusion in the proposed QSL, all vendors are required to provide country of origin information in the QSL FBO Package Worksheet. In addition, according to the DAPA Terms and Conditions, you must complete the DAPA TAA Certification for each item offered. If an item offered is a TAA Non-Compliant End Product, the Government can use this information to determine whether or not a waiver exists or if the Government will seek a waiver for the item. Unless a waiver exists or is granted, TAA Non-Compliant Country End Products cannot be added to the QSL and/or DAPA. Any questions concerning TAA may be directed to Donna Raday at DLA Troop Support, [email protected], 215-737-7885. The QSL for Gauze, Petrolatum will be established approximately February 2017 and is anticipated to be the basis of a Standardization Action. Qualified vendors will be invited approximately March 2017 to submit pricing proposals to enter into an Incentive Agreement for Gauze, Petrolatum. The government reserves the right to standardize or not standardize on Gauze, Petrolatum. A. Products & Performance Required The MMESOs are seeking product line items in the category of Gauze, Petrolatum. Within the MHS MTFs and operational procurement this product line has an estimated annual sales volume of $261,069. This forecast is based on historical usage data during a recent 12-month period. Twelve items are required for addition to the QSL and account for 99.34% ($259,335) of the total volume in sales ($261,069). The specifications for this project are shown in "Requirements to Qualify for QSL" section below. B. Instructions to Vendors Vendors interested in qualifying for inclusion in the QSL must provide an e-mail response to this QSL FBO Sources Sought notification to the lead MMESO POCs below. The vendor's responses must include all detailed information requested in the "Requirements to Qualify for QSL" section below and must also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); (3) Commercial and Government Entity (CAGE) Code; and (4) Identification of the Sources Sought notification to which the vendor is responding. Due to the potential for e-mail to be lost in transmission, from network security, etc., vendors are strongly encouraged to confirm with the lead MMESO that their e-mail submission has arrived. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before the due date and time should a problem occur with the first submission. As part of the "Requirements to Qualify for QSL", vendors must complete and submit the QSL FBO Package Worksheet. Any vendor experiencing difficulty opening the Worksheet may contact the MMESO POCs. The MMESO POC will provide a Worksheet copy via an alternate method (fax, e-mail or hard copy). Vendors that do not meet the deadline of COB 5:00 PM Central Daylight Time (CDT) on the date listed for closing in this QSL FBO Sources Sought notification will not be included in the lead MMESO's review to establish the QSL and thus will not be able to participate in the subsequent Standardization Action. C. Source Selection Procedures The MMESO Joint Product Review Board (JPRB) will serve as the forum for clinical recommendations for product selection and coordinate logistics efforts in support of DoD Components. The board is chaired by Designated Senior Logisticians (DSLs) and co-chaired by Designated Senior Clinicians (DSCs) in the MMESO Areas of Responsibility (AORs) and includes clinicians and logisticians for MTFs within each MMESO. The Clinical Advisory Committee (CAC) members are the deciding officials for this initiative. The MMESO DSLs and DSCs intend to review responses and evaluate products for selection to the QSL IAW FAR 9.2. Requirements to Qualify for QSL The requirements for this product line are outlined below. Complete answers and all supporting documentation must be provided with the vendor's submittal by the response date stated in this QSL FBO Sources Sought notification. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendors must provide responses to this Sources Sought notification via the QSL FBO Package Worksheet. 1. Vendor must have a DAPA or be in the process of applying for a DAPA number for the product line listed. Vendor must provide their DAPA number or provide documentation and date the DAPA number was applied for. Vendors who do not continue to process application for a DAPA number will not be considered for continued participation. 2. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor CARDINAL HEALTH, or must work with CARDINAL HEALTH to initiate an agreement. 3. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor OWENS & MINOR, or must work with OWENS & MINOR to initiate an agreement. 4. Vendor must have a government issued Commercial and Government Entity (CAGE) code assigned for products contained within the specific product group or be in the process of obtaining one. Vendors must validate that their account is Active in the System for Award Management (SAM) and provide CAGE Code. Vendors in the process of obtaining a CAGE Code must provide documentation to support that they have registered in SAM. Vendors who do not continue to process application for a CAGE Code and/or a SAM account will not be considered for continued participation. See https://www.sam.gov/portal/public/SAM/. 5. Vendor offered products shall be TAA compliant. End-items offered shall be manufactured or substantially transformed either in the U.S. or in Designated or Qualifying countries, unless it is determined that no functionally equivalent item is available from a compliant source. Therefore, the vendor at the item level must provide country of origin for all required items and any optional items offered. Vendor must provide product catalog & literature for any items offered in response to this Sources Sought Notification. Vendor must submit the following information via QSL FBO Package Worksheet for each offered product: Full item description, Distributor Part Number, Manufacturer Part Number, Manufacturer Name, Number of eaches in Unit of Sale, and country of origin. Only ONE Vendor Part Number (PN) should be provided for each item/sample. Vendor must send the same part number(s) for evaluation(s) as provided in response to the QSL FBO and as noted in the QSL FBO Package Worksheet. Required Products / Annual Usage in Units / 5.1 GAUZE PETROLATUM NO OVERWRAP 3" X 18" / 306,348 / 5.2 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE NO OVERWRAP 1" X 8" / 190,201 / 5.3 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE NO OVERWRAP 5" X 9" / 151,000 / 5.4 GAUZE PETROLATUM NO OVERWRAP 3" X 36" / 107,584 / 5.5 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE WITH OVERWRAP 5" X 9" / 65,353 / 5.6 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE WITH OVERWRAP 1" X 8" / 58,600 / 5.7 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE NO OVERWRAP 4" X 4" 26,100 / 5.8 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE NO OVERWRAP 2" X 2" / 10,802 / 5.9 GAUZE PETROLATUM NO OVERWRAP 3" X 9" / 10,780 / 5.10 GAUZE PETROLATUM 3% BISMUTH TRIBROMOPHENATE NO OVERWRAP 4" X 108" / 5,652 / 5.11 GAUZE PETROLATUM WITH OVERWRAP 3" X 18" / 1,832 / 5.12 GAUZE PETROLATUM WITH OVERWRAP 3" X 9" / 1,152 / 6. Vendor must provide Gauze, Petrolatum and Gauze, Petrolatum with 3% Bismuth Tribromophenate products that are not made with natural rubber latex and documentation to support this with initial submittal. 7. Vendor must provide Gauze, Petrolatum and Gauze, Petrolatum with 3% Bismuth Tribromophenate products with individual package labeling that identifies the package contents, size, single use, sterility, lot number, and expiration date and documentation to support this with initial submittal. Vendor may provide any or all of the additional items listed below following the same format as for requirement number 5. Item Descriptions / 1. GAUZE PETROLATUM NO OVERWRAP 0.5" X 72" / 2. GAUZE PETROLATUM NO OVERWRAP 1" X 36" / 3. GAUZE PETROLATUM WITH OVERWRAP 0.5" X 72" / 4. GAUZE PETROLATUM WITH OVERWRAP 3" X 36" / Evaluation After the lead MMESO receives all information required above, they will send each vendor, making a complete and approved submission, a written request to provide product samples to the Lead MMESO. The Lead MMESO "Ship to" Address will be provided as part of the request. To ensure your eligibility to participate, all products required for evaluation must be shipped to arrive at the MMESO South Office no later than 14 calendar days from issuance of the MMESO's request and must arrive at MMESO South Office no later than 5:00 PM local time from issuance of the MMESO's request. Products received after the stated date and time will not be included in review to establish the QSL nor will these products participate in the subsequent Standardization Action. The late arrival products will be destroyed upon receipt. Evaluations for this product line will be done by a panel of experts as a document review. Points of Contact (POCs): Mr. David Sheaffer, MMESO South Team Leader, [email protected], 210-536-6075; and Mr. Joe Winter, RN, MMESO South Clinical Analyst, [email protected], 210-536-6072. DLA Troop Support Medical Contracting Officer: Tara J. Perrien, [email protected] 215-737-8307. The purpose of this Modification is to extend the response date. There are no other changes at this time. The purpose of this Modification is to inform qualified entities interested in providing these services that the response date has been extended. Vendors interested in being added to the QSL will provide a response to the FBO Sources Sought notification via e-mail to the POCs identified in the FBO Sources Sought notification before the response due date. 22 Dec 2016 The purpose of this Modification to the QSL FBO is to inform vendors on the QSL List that the Incentive Agreement FBO has now been posted. Only Vendors on the QSL for this product line can be considered for an IA. All solicitation information is available electronically on the Federal Business Opportunities website. Solicitation External Reference: https://www.fbo.gov/spg/DLA/J3/DSCP-M/IAS-1611-12/listing.html Solicitation External Reference To Packages: https://www.fbo.gov/spg/DLA/J3/DSCP-M/IAS-1611-12/packages.html